209 related articles for article (PubMed ID: 2416270)
1. Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen.
Jaeckle KA; Graus F; Houghton A; Cardon-Cardo C; Nielsen SL; Posner JB
Ann Neurol; 1985 Nov; 18(5):592-600. PubMed ID: 2416270
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies in paraneoplastic cerebellar degeneration bind to cytoplasmic antigens of Purkinje cells in humans, rats and mice and are of multiple immunoglobulin classes.
Smith JL; Finley JC; Lennon VA
J Neuroimmunol; 1988 Apr; 18(1):37-48. PubMed ID: 3346369
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma.
Greenlee JE; Brashear HR
Ann Neurol; 1983 Dec; 14(6):609-13. PubMed ID: 6360029
[TBL] [Abstract][Full Text] [Related]
4. A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration.
Anderson NE; Budde-Steffen C; Wiley RG; Thurman L; Rosenblum MK; Nadeau SE; Posner JB
Neurology; 1988 Jul; 38(7):1018-26. PubMed ID: 3290700
[TBL] [Abstract][Full Text] [Related]
5. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
[TBL] [Abstract][Full Text] [Related]
6. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration.
Furneaux HM; Rosenblum MK; Dalmau J; Wong E; Woodruff P; Graus F; Posner JB
N Engl J Med; 1990 Jun; 322(26):1844-51. PubMed ID: 2348838
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a cDNA encoding a 34-kDa Purkinje neuron protein recognized by sera from patients with paraneoplastic cerebellar degeneration.
Furneaux HM; Dropcho EJ; Barbut D; Chen YT; Rosenblum MK; Old LJ; Posner JB
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2873-7. PubMed ID: 2649898
[TBL] [Abstract][Full Text] [Related]
8. Anti-Purkinje cell antibody producing B-cell lines from a patient with paraneoplastic cerebellar degeneration.
Tsukamoto T; Yoshie O; Tada K; Iwasaki Y
Arch Neurol; 1987 Aug; 44(8):833-7. PubMed ID: 3307712
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options.
Dropcho EJ
Ann Neurol; 1995 May; 37 Suppl 1():S102-13. PubMed ID: 8968221
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune paraneoplastic cerebellar degeneration: ultrastructural localization of antibody-binding sites in Purkinje cells.
Rodriguez M; Truh LI; O'Neill BP; Lennon VA
Neurology; 1988 Sep; 38(9):1380-6. PubMed ID: 3045692
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune paraneoplastic cerebellar degeneration: immunohistological localization of antibody-binding sites.
Nardelli E; Currò-Dossi B; Rizzuto N; Graus F
Clin Neurol Neurosurg; 1995 Feb; 97(1):89-94. PubMed ID: 7540522
[TBL] [Abstract][Full Text] [Related]
12. Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration.
Cunningham J; Graus F; Anderson N; Posner JB
Neurology; 1986 Sep; 36(9):1163-8. PubMed ID: 3528917
[TBL] [Abstract][Full Text] [Related]
13. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.
Tanaka M; Tanaka K; Onodera O; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):95-100. PubMed ID: 7788981
[TBL] [Abstract][Full Text] [Related]
14. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
Tanaka K; Tanaka M; Onodera O; Tsuji S
Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
[TBL] [Abstract][Full Text] [Related]
15. Selective concentration of anti-Purkinje cell antibody in the CSF of two patients with paraneoplastic cerebellar degeneration.
Graus F; Segurado OG; Tolosa E
Acta Neurol Scand; 1988 Sep; 78(3):210-3. PubMed ID: 3227806
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic cerebellar degeneration: clinical-immunological correlations.
Anderson NE; Rosenblum MK; Posner JB
Ann Neurol; 1988 Oct; 24(4):559-67. PubMed ID: 3239956
[TBL] [Abstract][Full Text] [Related]
17. [Paraneoplastic cerebellar degeneration].
Nakano R; Sato S
Nihon Rinsho; 1994 Nov; 52(11):3000-5. PubMed ID: 7996701
[TBL] [Abstract][Full Text] [Related]
18. Neuronal calcium channel autoantibodies coexisting with type 1 Purkinje cell cytoplasmic autoantibodies (PCA-1 or "anti-Yo").
Lennon VA; Kryzer TJ
Neurology; 1998 Jul; 51(1):327-9. PubMed ID: 9674845
[No Abstract] [Full Text] [Related]
19. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration.
Verschuuren J; Chuang L; Rosenblum MK; Lieberman F; Pryor A; Posner JB; Dalmau J
Acta Neuropathol; 1996; 91(5):519-25. PubMed ID: 8740233
[TBL] [Abstract][Full Text] [Related]
20. Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
Tanaka M; Tanaka K; Idezuka J; Tsuji S
Exp Neurol; 1998 Apr; 150(2):337-8. PubMed ID: 9527904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
